Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Change in Account Payables: 2020-2024

Historic Change in Account Payables for Core Scientific (CORZ) over the last 5 years, with Dec 2024 value amounting to -$12.3 million.

  • Core Scientific's Change in Account Payables fell 674.38% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.2 million, marking a year-over-year decrease of 124.50%. This contributed to the annual value of -$12.3 million for FY2024, which is 110.32% down from last year.
  • Per Core Scientific's latest filing, its Change in Account Payables stood at -$12.3 million for FY2024, which was down 110.32% from $118.9 million recorded in FY2023.
  • Core Scientific's Change in Account Payables' 5-year high stood at $118.9 million during FY2023, with a 5-year trough of -$22.0 million in FY2021.
  • In the last 3 years, Core Scientific's Change in Account Payables had a median value of $26.7 million in 2022 and averaged $44.5 million.
  • Per our database at Business Quant, Core Scientific's Change in Account Payables crashed by 1,142.43% in 2021 and then skyrocketed by 345.14% in 2023.
  • Core Scientific's Change in Account Payables (Yearly) stood at -$1.8 million in 2020, then slumped by 1,142.43% to -$22.0 million in 2021, then skyrocketed by 221.47% to $26.7 million in 2022, then soared by 345.14% to $118.9 million in 2023, then tumbled by 110.32% to -$12.3 million in 2024.